{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:06:52Z","timestamp":1774789612123,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Th. Maigaards Eftf. Fru Lily Benthine Lunds Fond"},{"DOI":"10.13039\/100007606","name":"Aarhus University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007606","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.neuropharm.2014.12.025","type":"journal-article","created":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T01:00:50Z","timestamp":1420592450000},"page":"97-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Decreased in\u00a0vivo \u03b12 adrenoceptor binding in the Flinders Sensitive Line rat model of depression"],"prefix":"10.1016","volume":"91","author":[{"given":"Anne M.","family":"Landau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny-Ann","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1692-5975","authenticated-orcid":false,"given":"Thea P.","family":"Lillethorup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregers","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris J.","family":"Doudet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2014.12.025_bib1","doi-asserted-by":"crossref","first-page":"808713","DOI":"10.1155\/2013\/808713","article-title":"Effects of anesthesia and species on the uptake or binding of radioligands in\u00a0vivo in the Gottingen minipig","volume":"2013","author":"Alstrup","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV","author":"American Psychiatric Association","year":"2013"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.neuropharm.2014.12.025_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/13651500600637056","article-title":"Serotonin noradrenaline reuptake inhibitors: a new generation of treatment for anxiety disorders","volume":"10","author":"Baldwin","year":"2006","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/j.1552-4604.1994.tb04981.x","article-title":"Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure","volume":"34","author":"Biaggioni","year":"1994","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004850-200307000-00001","article-title":"Noradrenaline in mood and anxiety disorders: basic and clinical studies","volume":"18","author":"Brunello","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archpsyc.1984.01790190025003","article-title":"Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder","volume":"41","author":"Charney","year":"1984","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib7","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/hipo.20718","article-title":"Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression","volume":"20","author":"Chen","year":"2010","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0165-1781(80)90051-7","article-title":"Presynaptic noradrenergic regulation during depression and antidepressant drug treatment","volume":"3","author":"Cohen","year":"1980","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib9","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.neubiorev.2012.07.011","article-title":"alpha2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy","volume":"36","author":"Cottingham","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib10","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/sj.npp.1300459","article-title":"Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims","volume":"29","author":"Escriba","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jps.2600830718","article-title":"Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil","volume":"83","author":"Gandelman","year":"1994","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1471-4159.1994.63010256.x","article-title":"Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims","volume":"63","author":"Gonzalez","year":"1994","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.mp.4001067","article-title":"Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors","volume":"7","author":"Gonzalez-Maeso","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neuint.2005.11.012","article-title":"Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: an autoradiographic study","volume":"48","author":"Hasegawa","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib15","first-page":"2008","article-title":"Detection of alpha2-adrenergic receptors in brain of living pig with 11C-yohimbine","volume":"47","author":"Jakobsen","year":"2006","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.euroneuro.2006.06.011","article-title":"Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression","volume":"17","author":"Jimenez-Vasquez","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.psych.48.1.191","article-title":"The effects of stressful life events on depression","volume":"48","author":"Kessler","year":"1997","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/070674371305800203","article-title":"Gene-environment interactions in major depressive disorder","volume":"58","author":"Klengel","year":"2013","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib19","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.pnpbp.2010.05.029","article-title":"Hepatic drug metabolizing profile of Flinders Sensitive Line rat model of depression","volume":"34","author":"Kotsovolou","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2632-6","article-title":"Amphetamine challenge decreases yohimbine binding to alpha2 adrenoceptors in Landrace pig brain","volume":"222","author":"Landau","year":"2012","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib21","first-page":"S36","article-title":"Update: inhibition plots of [C-11]yohimbine binding yield consistent estimates of non-displaceable volumes of distribution in multiple tests","volume":"32","author":"Landau","year":"2012","journal-title":"J.\u00a0Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","article-title":"Imaging synaptic neurotransmission with in\u00a0vivo binding competition techniques: a critical review","volume":"20","author":"Laruelle","year":"2000","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","article-title":"Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects","volume":"10","author":"Logan","year":"1990","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/87865","article-title":"The cellular neurobiology of depression","volume":"7","author":"Manji","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib25","series-title":"Depression, a Global Public Health Concern","author":"Marcus","year":"2012"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/157015908787386078","article-title":"Triple reuptake inhibitors: the next generation of antidepressants","volume":"6","author":"Marks","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(02)01728-6","article-title":"Elevated agonist binding to alpha2-adrenoceptors in the locus coeruleus in major depression","volume":"53","author":"Ordway","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0006-3223(86)90007-7","article-title":"Selective breeding for increased cholinergic function: development of a new animal model of depression","volume":"21","author":"Overstreet","year":"1986","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neubiorev.2005.03.015","article-title":"The Flinders Sensitive Line rat: a selectively bred putative animal model of depression","volume":"29","author":"Overstreet","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejphar.2004.04.010","article-title":"Antidepressant effects of citalopram and CRF receptor antagonist CP-154,526 in a rat model of depression","volume":"492","author":"Overstreet","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00432254","article-title":"Selective breeding for diisopropyl fluorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists","volume":"78","author":"Overstreet","year":"1982","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.111.005397","article-title":"The flinders sensitive line rat model of depression\u201325 years and still producing","volume":"65","author":"Overstreet","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib33","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1073\/pnas.86.13.5128","article-title":"Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance","volume":"86","author":"Pearce","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib34","article-title":"Quantification of [11C]yohimbine binding to \u03b12 adrenoceptors in rat brain in\u00a0vivo","author":"Phan","year":"2014","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib35","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0006-3223(99)00127-4","article-title":"Role of norepinephrine in the pathophysiology and treatment of mood disorders","volume":"46","author":"Ressler","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1460-9568.2009.06840.x","article-title":"Antidepressant treatment facilitates dopamine release and drug seeking behavior in a genetic animal model of depression","volume":"30","author":"Roth-Deri","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib37","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.neuroimage.2003.07.011","article-title":"Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain","volume":"20","author":"Rubins","year":"2003","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2014.12.025_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0006-8993(02)04167-7","article-title":"Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression","volume":"965","author":"Schwartz","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0163-7258(01)00156-5","article-title":"Yohimbine: a clinical review","volume":"91","author":"Tam","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.97.1.325","article-title":"Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone","volume":"97","author":"Wong","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(99)01214-7","article-title":"Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment","volume":"824","author":"Zangen","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2014.12.025_bib43","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/jps.22566","article-title":"Substrate- and species-dependent inhibition of P-glycoprotein-mediated transport: implications for predicting in\u00a0vivo drug interactions","volume":"100","author":"Zolnerciks","year":"2011","journal-title":"J.\u00a0Pharm. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814004766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814004766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T11:04:41Z","timestamp":1617620681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814004766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":43,"alternative-id":["S0028390814004766"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.12.025","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased in\u00a0vivo \u03b12 adrenoceptor binding in the Flinders Sensitive Line rat model of depression","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2014.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}